Good evening :)
$
₹
Cingulate Inc

Cingulate Inc

CING

NASDAQ
$4.250.23% (+0.01)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Biotechnology

Micro Cap

With a market cap of $66.3M the stock is ranked 4925

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.92
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-3.51
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 4 analysts reports

Buy
4 analysts
Hold
0 analyst
Sell
0 analyst

Price Upside

+400%

Earnings Growth

+49.36%

Rev. Growth

—

See Detailed Forecast

Company Profile

Company Profile

P/E Ratio
50.65
50.65
1Y Return
31.59%
31.59%
Buy Reco %
79.31
79.31
P/E Ratio
27.73
27.73
1Y Return
46.88%
46.88%
Buy Reco %
35.29
35.29
P/E Ratio
—
—
1Y Return
35.24%
35.24%
Buy Reco %
78.57
78.57
P/E Ratio
35.33
35.33
1Y Return
31.43%
31.43%
Buy Reco %
81.25
81.25
P/E Ratio
—
—
1Y Return
944.75%
944.75%
Buy Reco %
17.39
17.39
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Financials

Financials

Income

Balance Sheet

Cash Flow

-7.3
-6.2
-9.3
-5.8
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue-3.840012.98000000
Net Income-0-0-0-0-0-0-0-0-0-0
Net Profit Margin0.07%---0.04%------

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Cingulate Inc -2.92-
AbbVie Inc50.6550.450.58
Amgen Inc27.7321.332.75

Price Comparison

Price Comparison

Compare CING with any stock or ETF
Compare CING with any stock or ETF
Comparing from
CING
ABBV
AMGN
Loading...

Frequently asked questions

  1. Cingulate Inc (CING) share price today is $4.25 as of November 7, 2026 at 2:29 AM IST. The stock touched a day high of $4.34 and a day low of $4.22.

  2. Cingulate Inc stock trades on NASDAQ under the ticker symbol CING.

  3. Cingulate Inc's market capitalization is $66.31M as of November 7, 2026 at 2:29 AM IST.

  4. Cingulate Inc's price-to-earnings (P/E) ratio is N/A as of November 7, 2026.

  5. Cingulate Inc's price-to-book (P/B) ratio is 2.92 as of November 7, 2026.

  6. Yes, You can buy Cingulate Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Cingulate Inc shares in three steps: 1. Search Cingulate Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Cingulate Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Cingulate Inc (CING) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 2.3529 shares at the current price of $4.25.

Loading...